193 related articles for article (PubMed ID: 11952987)
1. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium.
Gulliksson H; AuBuchon JP; Vesterinen M; Sandgren P; Larsson S; Pickard CA; Herschel I; Roger J; Tracy JE; Langweiler M;
Vox Sang; 2002 Apr; 82(3):131-6. PubMed ID: 11952987
[TBL] [Abstract][Full Text] [Related]
2. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium.
Gulliksson H; AuBuchon JP; Cardigan R; van der Meer PF; Murphy S; Prowse C; Richter E; Ringwald J; Smacchia C; Slichter S; de Wildt-Eggen J
Vox Sang; 2003 Oct; 85(3):199-205. PubMed ID: 14516450
[TBL] [Abstract][Full Text] [Related]
3. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
[TBL] [Abstract][Full Text] [Related]
4. Storage of platelets in additive solutions: the effects of magnesium and potassium on the release of RANTES, beta-thromboglobulin, platelet factor 4 and interleukin-7, during storage.
Shanwell A; Falker C; Gulliksson H
Vox Sang; 2003 Oct; 85(3):206-12. PubMed ID: 14516451
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
[TBL] [Abstract][Full Text] [Related]
6. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality.
Ringwald J; Walz S; Zimmermann R; Zingsem J; Strasser E; Weisbach V; Eckstein R
Vox Sang; 2005 Jul; 89(1):11-8. PubMed ID: 15938735
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of in vitro storage properties of apheresis platelets suspended in a bicarbonate-containing additive solution with low levels of plasma and stored with a 24-hour interruption of agitation.
Skripchenko A; Turgeon A; Thompson-Montgomery D; Awatefe H; Wagner SJ
Vox Sang; 2014 May; 106(4):337-43. PubMed ID: 24330192
[TBL] [Abstract][Full Text] [Related]
8. Storage of platelets in additive solutions: effects of phosphate.
Gulliksson H; Larsson S; Kumlien G; Shanwell A
Vox Sang; 2000; 78(3):176-84. PubMed ID: 10838519
[TBL] [Abstract][Full Text] [Related]
9. Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days.
Cid J; Magnano L; Molina P; Diaz-Ricart M; Martínez N; Maymó RM; Puig L; Lozano M; Escolar G; Galán AM
Transfusion; 2014 Feb; 54(2):426-33. PubMed ID: 23721299
[TBL] [Abstract][Full Text] [Related]
10. Platelet storage media.
Gulliksson H
Vox Sang; 2014 Oct; 107(3):205-12. PubMed ID: 24976010
[TBL] [Abstract][Full Text] [Related]
11. Washing platelets with new additive solutions: aspects on the in vitro quality after 48 hours of storage.
Ringwald J; Althoff F; Zimmermann R; Strasser E; Weisbach V; Zingsem J; Eckstein R
Transfusion; 2006 Feb; 46(2):236-43. PubMed ID: 16441601
[TBL] [Abstract][Full Text] [Related]
12. The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover.
Johnson L; Winter KM; Reid S; Hartkopf-Theis T; Marschner S; Goodrich RP; Marks DC
Vox Sang; 2011 Oct; 101(3):208-14. PubMed ID: 21492184
[TBL] [Abstract][Full Text] [Related]
13. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
[TBL] [Abstract][Full Text] [Related]
14. Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma.
Gyongyossy-Issa MI; Zhang JG; Culibrk B; Hunter F; Levin E; Scammell K; Weiss S; Holmes DL; Holme S
Vox Sang; 2009 Aug; 97(2):102-9. PubMed ID: 19508670
[TBL] [Abstract][Full Text] [Related]
15. Platelet storage in more than 90% additive solution containing glucose and bicarbonate has the potential to increase shelf life.
Bashir S; Kemsley K; Min K; Swann ID; Cardigan R
Transfusion; 2018 Dec; 58(12):2959-2968. PubMed ID: 30265746
[TBL] [Abstract][Full Text] [Related]
16. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality.
van der Meer PF; Pietersz RN; Reesink HW
Transfusion; 2004 Aug; 44(8):1204-11. PubMed ID: 15265125
[TBL] [Abstract][Full Text] [Related]
17. [Morphology and function of platelets stored in modified platelet additive solution at low temperature].
Wang X; Shi RH; Li J; Liu FJ; Chen HM; Zhao SM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):797-801. PubMed ID: 19549411
[TBL] [Abstract][Full Text] [Related]
18. Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction.
Isola H; Ravanat C; Rudwill F; Pongerard A; Haas D; Eckly A; Gachet C; Hechler B
Transfusion; 2021 Mar; 61(3):919-930. PubMed ID: 33527430
[TBL] [Abstract][Full Text] [Related]
19. Investigating the effect of a platelet additive solution on apheresis platelet and fibrin network ultrastructure.
Pretorius E; Crookes R; Oberholzer HM; van der Spuy WJ
Transfus Apher Sci; 2010 Dec; 43(3):347-351. PubMed ID: 21036668
[TBL] [Abstract][Full Text] [Related]
20. PAS or plasma for storage of platelets? A concise review.
van der Meer PF
Transfus Med; 2016 Oct; 26(5):339-342. PubMed ID: 27273164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
